BioStem Technologies Reports First Quarter 2026 Financial Results

POMPANO BEACH, Fla., May 14, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the first quarter ended March 31, 2026. Recent Financial and Business Highlights “The […]

The post BioStem Technologies Reports First Quarter 2026 Financial Results first appeared on Prism Media Wire.